contact us
subTop OurProjects

More than half of patients affected by the most common blinding diseases in the world (glaucoma, diabetic retinopathy) are not detected in time. The reason is that at their initial stages, these common conditions (in Singapore, Asia, and worldwide) are not visually bothering, and remain undiagnosed until late stages.

Based on recent neuroscientific discoveries and on more than 10 years of personal research in this field, the team has built an original, affordable biomedical device, using the medical principle that quantification of pupillary responses to specific light can provide an accurate indication of the retinal health. Preliminary work has shown excellent accuracy for detection of glaucoma and diabetic retinopathy (sensitivity>93%).

Project Deliverables

The team aims to i) a handheld pupillometer, and ii) Clinical validate and optimize the prototype


Principal Investigator: Prof Dan Milea

Institution: Singapore Eye Research Institute

NHIC Ref: NHIC-I2D-1708181

 

 

See all MEDTECH projects >

targetGroup_clinicianInnovators
targetGroup_ResearchAdministrator
targetGroup_IndustryPartner
targetGroup_Investor